Normal expression of tissue factor, thrombomodulin, and annexin V in placentas from women with antiphospholipid syndrome
- 1 July 1999
- journal article
- Published by Elsevier BV in American Journal of Obstetrics and Gynecology
- Vol. 181 (1), 180-189
- https://doi.org/10.1016/s0002-9378(99)70457-6
Abstract
No abstract availableThis publication has 20 references indexed in Scilit:
- Thromboprophylaxis in Antiphospholipid Syndrome Pregnancies with Previous Cerebral Arterial Thrombotic Events: Is Warfarin Preferable?Thrombosis and Haemostasis, 1998
- Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies)BMJ, 1997
- Antiphospholipid antibody–associated recurrent pregnancy loss: Treatment with heparin and low-dose aspirin is superior to low-dose aspirin aloneAmerican Journal of Obstetrics and Gynecology, 1996
- Intravenous immunoglobulin therapy for the antiphospholipid syndrome in pregnancyAmerican Journal of Obstetrics and Gynecology, 1995
- The Immunobiology and Obstetrical Consequences of Antiphospholipid AntibodiesObstetrical & Gynecological Survey, 1994
- Comparison of the primary and secondary antiphospholipid syndrome: A European multicenter study of 114 patientsAmerican Journal Of Medicine, 1994
- The antiphospholipid syndrome: ten years onThe Lancet, 1993
- Repeated fetal losses associated with antiphospholipid antibodies: A collaborative randomized trial comparing prednisone with low-dose heparin treatmentAmerican Journal of Obstetrics and Gynecology, 1992
- Prednisone does not prevent recurrent fetal death in women with antiphospholipid antibodyAmerican Journal of Obstetrics and Gynecology, 1989
- Decidual vasculopathy and extensive placental infarction in a patient with repeated thromboembolic accidents, recurrent fetal loss, and a lupus anticoagulantAmerican Journal of Obstetrics and Gynecology, 1982